Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocrine Therapy in Early Breast Cancer
Katja Krauss, Elmar Stickeler
Breast Care (2020) Vol. 15, Iss. 4, pp. 337-346
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Breast cancer: an up‐to‐date review and future perspectives
Ruoxi Hong, Binghe Xu
Cancer Communications (2022) Vol. 42, Iss. 10, pp. 913-936
Open Access | Times Cited: 191
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
Michael Gnant, Florian Fitzal, Gabriel Rinnerthaler, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 5, pp. 395-405
Open Access | Times Cited: 118
Contemporaneous symptom networks and correlates during endocrine therapy among breast cancer patients: A network analysis
Feng Jing, Zheng Zhu, Jiajia Qiu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Impact of Imaging Biomarkers and AI on Breast Cancer Management: A Brief Review
Gehad A. Saleh, Nihal M. Batouty, Abdelrahman Gamal, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5216-5216
Open Access | Times Cited: 16
Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies
Govinda R Hancock, Jason Gertz, Rinath Jeselsohn, et al.
Endocrinology (2024) Vol. 165, Iss. 6
Closed Access | Times Cited: 6
Ocular Toxicity of Targeted Anticancer Agents
Blake H. Fortes, Prashant D. Tailor, Lauren A. Dalvin
Drugs (2021) Vol. 81, Iss. 7, pp. 771-823
Closed Access | Times Cited: 38
Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer
Veronica Jones, Hongwei Yin, Yuan Yuan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Detection of ESR1 Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients
Samiksha A. Borkar, Fenja Markus, Agnes Oetting, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1266-1266
Open Access
The Present and Future of Neoadjuvant Endocrine Therapy for Breast Cancer Treatment
Covadonga Martí, José Ignacio Sánchez-Méndez
Cancers (2021) Vol. 13, Iss. 11, pp. 2538-2538
Open Access | Times Cited: 19
Christia vespertilionis extract induced antiproliferation and apoptosis in breast cancer (MCF7) cells
Noor Zafirah Ismail, Ismail Abiola Adebayo, Wan Ahmad Syazani Mohamed, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 11, pp. 7361-7370
Closed Access | Times Cited: 18
Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review
Deborah Obehi Onwusah, Elizabeth Ojewole, Moses John Chimbari
JCO Global Oncology (2023), Iss. 9
Open Access | Times Cited: 7
Synthesis and computational insights of hybrid heterocyclic bis-chalcone compounds and their cytotoxic effects against breast cancer cells
Sadiq Abubakar, Melati Khairuddean, Noor Zafirah Ismail, et al.
Results in Chemistry (2024) Vol. 7, pp. 101464-101464
Open Access | Times Cited: 2
Adjuvant endocrine therapy and risk of contralateral breast cancer: a systematic review and meta-analysis of observational studies
Rajrupa Ghosh, Ruth M. Pfeiffer, Sylvia Roberts, et al.
Cancer Causes & Control (2024)
Closed Access | Times Cited: 2
Therapeutics targeting the metastatic breast cancer bone microenvironment
Claire L. Ihle, Sabrina J. Wright-Hobart, Philip Owens
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108280-108280
Closed Access | Times Cited: 12
Uniaxial and Coaxial Nanofibers PCL/Alginate or PCL/Gelatine Transport and Release Tamoxifen and Curcumin Affecting the Viability of MCF7 Cell Line
Diego Fernando Suárez, Ana Delia Pinzón-García, Rubén D. Sinisterra, et al.
Nanomaterials (2022) Vol. 12, Iss. 19, pp. 3348-3348
Open Access | Times Cited: 12
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells
Laurence Booth, Cameron West, Robert P. Moore, et al.
Oncotarget (2022) Vol. 13, Iss. 1, pp. 92-104
Open Access | Times Cited: 11
Breast cancer status, grading system, etiology, and challenges in Asia: an updated review
Xiao Jian Tan, Wai Loon Cheor, Ee Meng Cheng, et al.
ONCOLOGIE (2023) Vol. 25, Iss. 2, pp. 99-110
Open Access | Times Cited: 6
The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study
Covadonga Martí, Laura Yébenes, José M. Oliver, et al.
Current Oncology (2022) Vol. 29, Iss. 4, pp. 2199-2210
Open Access | Times Cited: 10
Impact of estrogen receptor expression on prognosis of ovarian cancer according to antibody clone used for immunohistochemistry: a meta-analysis
Chun Wai Ng, Kwong‐Kwok Wong
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Downregulation of RPS14 inhibits the proliferation and metastasis of estrogen receptor-positive breast cancer cells
Xiu Wang, Shuang Yao, Guanghua Luo, et al.
Anti-Cancer Drugs (2021) Vol. 32, Iss. 10, pp. 1019-1028
Closed Access | Times Cited: 13
Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2- Early Breast Cancer
Marta Truffi, F Piccotti, Sara Albasini, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13
Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer
Fernanda Cardoso da Silva, Douglas Cardoso Brandão, Everton Allan Ferreira, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1466-1466
Open Access | Times Cited: 5
Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study
Deborah Obehi Onwusah, Elizabeth Ojewole, Tawanda Manyangadze, et al.
Patient Preference and Adherence (2023) Vol. Volume 17, pp. 2821-2839
Open Access | Times Cited: 5
Symptom Clusters and Quality of Life in Patients With Breast Cancer Receiving Endocrine Therapy in China
Feng Jing, Zheng Zhu, Jiajia Qiu, et al.
Seminars in Oncology Nursing (2023) Vol. 39, Iss. 4, pp. 151443-151443
Open Access | Times Cited: 4
Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial
John M.S. Bartlett, Keying Xu, Jenna Wong, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 8, pp. 1509-1517
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top